These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10541301)

  • 21. The role of tissue factor in renal ischemic reperfusion injury of the rat.
    Ushigome H; Sano H; Okamoto M; Kadotani Y; Nakamura K; Akioka K; Yoshimura R; Ohmori Y; Yoshimura N
    J Surg Res; 2002 Feb; 102(2):102-9. PubMed ID: 11796005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of tissue factor pathway in human umbilical vein and adult saphenous vein endothelial cells: implications for newborn hemostasis and for laboratory models of endothelial cell function.
    Grabowski EF; Carter CA; Ingelfinger JR; Tsukurov O; Conroy N; Abbott WM; Orkin RW
    Pediatr Res; 1999 Dec; 46(6):742-7. PubMed ID: 10590033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localized control of blood coagulation.
    McGee MP; Foster S; Wang X
    J Exp Med; 1994 Jun; 179(6):1847-54. PubMed ID: 8195712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue factor and tissue factor pathway inhibitor in nasal mucosa and nasal secretions of chronic rhinosinusitis with nasal polyp.
    Shimizu S; Ogawa T; Takezawa K; Tojima I; Kouzaki H; Shimizu T
    Am J Rhinol Allergy; 2015; 29(4):235-42. PubMed ID: 26163243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in tumor necrosis factor-induced endothelial cell procoagulant activity by hyperthermia.
    Carroll NM; Elaraj DM; Puhlmann M; Weinreich DM; Turner EM; Xu H; Alexander HR
    Int J Cancer; 2004 Sep; 111(3):457-62. PubMed ID: 15221977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF.
    Friedl J; Puhlmann M; Bartlett DL; Libutti SK; Turner EN; Gnant MF; Alexander HR
    Blood; 2002 Aug; 100(4):1334-9. PubMed ID: 12149215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An oligonucleotide decoy for nuclear factor-kappa B inhibits tumor necrosis factor-alpha-induced human umbilical cord vein endothelial cell tissue factor expression in vitro.
    Wang L; Wei W; Hu Y; Song S; Yan Z
    Blood Coagul Fibrinolysis; 2004 Sep; 15(6):483-90. PubMed ID: 15311157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2007; 120(6):871-6. PubMed ID: 17331567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluid shear stress attenuates tumor necrosis factor-alpha-induced tissue factor expression in cultured human endothelial cells.
    Matsumoto Y; Kawai Y; Watanabe K; Sakai K; Murata M; Handa M; Nakamura S; Ikeda Y
    Blood; 1998 Jun; 91(11):4164-72. PubMed ID: 9596663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue factor pathway inhibitor production by human proximal tubular epithelial cells in culture.
    Sugawara T; Yamabe H; Osawa H; Kaizuka M; Shirato K; Nakamura M; Tamura M; Okumura K
    Thromb Res; 2003 May; 110(2-3):141-7. PubMed ID: 12893029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction.
    Steppich B; Mattisek C; Sobczyk D; Kastrati A; Schömig A; Ott I
    Thromb Haemost; 2005 Jan; 93(1):35-9. PubMed ID: 15630488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catabolism of factor VIIa bound to tissue factor in fibroblasts in the presence and absence of tissue factor pathway inhibitor.
    Iakhiaev A; Pendurthi UR; Voigt J; Ezban M; Vijaya Mohan Rao L
    J Biol Chem; 1999 Dec; 274(52):36995-7003. PubMed ID: 10601255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration.
    Gori AM; Pepe G; Attanasio M; Falciani M; Abbate R; Prisco D; Fedi S; Giusti B; Brunelli T; Giusti B; Brunelli T; Comeglio P; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1999 Apr; 81(4):589-93. PubMed ID: 10235445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium.
    Kostovski E; Dahm AE; Iversen N; Hjeltnes N; Østerud B; Sandset PM; Iversen PO
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):254-9. PubMed ID: 21297449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Roles of intercellar Ca2+ and protein kinase C played in tissue factor pathway inhibitor and tissue factor expression in human umbilic vein endothelial cells].
    Han JZ; Li JC; Qu SL; He SL
    Sheng Li Xue Bao; 1997 Dec; 49(6):675-8. PubMed ID: 9863191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncostatin M induces procoagulant activity in human vascular smooth muscle cells by modulating the balance between tissue factor and tissue factor pathway inhibitor.
    Mirshahi F; Vasse M; Tedgui A; Li H; Merval R; Legrand E; Vannier JP; Soria J; Soria C
    Blood Coagul Fibrinolysis; 2002 Jul; 13(5):449-55. PubMed ID: 12138373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin use during dialysis sessions induces an increase in the antiangiogenic factor soluble Flt1.
    Lavainne F; Meffray E; Pepper RJ; Néel M; Delcroix C; Salama AD; Fakhouri F
    Nephrol Dial Transplant; 2014 Jun; 29(6):1225-31. PubMed ID: 24516233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and biology of tissue factor pathway inhibitor.
    Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
    Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue factor expression is differentially modulated by cyclic mechanical strain in various human endothelial cells.
    Silverman MD; Manolopoulos VG; Unsworth BR; Lelkes PI
    Blood Coagul Fibrinolysis; 1996 Apr; 7(3):281-8. PubMed ID: 8735134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of tissue factor and tissue factor pathway inhibitor in monocytes in response to bacterial lipopolysaccharide and phorbolester.
    van der Logt CP; Dirven RJ; Reitsma PH; Bertina RM
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):211-20. PubMed ID: 8054453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.